Skip to content
ppharmaranks
Menu
Class IIOngoing

Azelaic Acid Gel recall

FDA recall D-0662-2025 · initiated Sep 17, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Oct 1, 2025How we research

Glenmark Pharmaceuticals Inc., USA recalled Azelaic Acid Gel in Sep 2025 — an FDA Class II recall (D-0662-2025) because CGMP Deviations: Market complaints received for gritty texture (grainy).

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations: Market complaints received for gritty texture (grainy)

The manufacturing process itself

The FDA found the process itself out of compliance, usually before any defective product was identified.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Batch # 19252524, Exp Date: May 2027

Quantity recalled: 13824 tubes

Details

Product
Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-626-52
Recalling company
Glenmark Pharms
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within the United States
Initiated
Sep 17, 2025
FDA report date
Oct 1, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Azelaic Acid Gel recalled?
Glenmark Pharmaceuticals Inc., USA recalled Azelaic Acid Gel in Sep 2025 — an FDA Class II recall (D-0662-2025) because CGMP Deviations: Market complaints received for gritty texture (grainy). May cause temporary or medically reversible harm; low probability of serious harm.
Why was Azelaic Acid Gel recalled?
Per the FDA enforcement record, the reason for recall D-0662-2025 was: CGMP Deviations: Market complaints received for gritty texture (grainy)
Is a recalled Azelaic Acid Gel dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Azelaic Acid Gel are affected?
Distributed: Nationwide within the United States. The recall covers these lots — Batch # 19252524, Exp Date: May 2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0662-2025.

Source: openFDA Drug Enforcement record D-0662-2025

← All drug recalls